eprintid: 60183
rev_number: 1
eprint_status: archive
userid: 1
dir: disk0/00/06/01/83
datestamp: 2026-05-26 15:51:30
lastmod: 2026-05-26 15:51:30
status_changed: 2026-05-26 15:51:30
type: article
metadata_visibility: show
sword_depositor: 1
creators_name: Kurbanova, Z.Ch.
creators_name: Z.A, Sayfuddinova
creators_name: Begmatova3, .A.
title: CLINICAL DYNAMICS OF HEMOSTATIC SYSTEM PARAMETERS AND THE ROLE OF BIOMARKERS IN PATIENTS WITH IMMUNE MICROTHROMBOVASCULITIS UNDER ANTICOAGULANT THERAPY
ispublished: pub
subjects: Immune microthrombovasculitis, anticoagulant therapy, hemostatic parameters, D-dimer, fibrinogen, von Willebrand factor, C-reactive protein.
keywords: Immune microthrombovasculitis, anticoagulant therapy, hemostatic parameters, D-dimer, fibrinogen, von Willebrand factor, C-reactive protein.
note: Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/3958)
abstract: Immune microthrombovasculitis (IMTV) is a rare disorder characterized by immune-mediated microvascular thrombosis, often requiring anticoagulant therapy to mitigate thrombotic complications. This prospective study investigates the dynamics of hemostatic system parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and biomarkers (von Willebrand factor [vWF], C-reactive protein [CRP]) in 40 patients with IMTV over a 12-month period. Patients received either warfarin or direct oral anticoagulants (DOACs). Significant reductions in D-dimer levels (from 1.3 µg/mL to 0.5 µg/mL, p<0.01) and stabilization of APTT were observed in 85% of DOAC-treated patients. Fibrinogen levels remained elevated in 55% of patients, correlating with CRP (r=0.68, p<0.01). Elevated vWF levels at baseline (185 IU/dL) decreased modestly (145 IU/dL, p=0.04), reflecting partial endothelial recovery. Persistent vWF elevation was associated with a 20% incidence of recurrent thrombotic events. These findings underscore the utility of hemostatic parameters and biomarkers in monitoring therapy efficacy and predicting outcomes, advocating for personalized treatment strategies in IMTV.
date: 2025-06-09
date_type: published
publisher: Center for Tech and Media Research
official_url: https://mjstjournal.com/index.php/mjst/article/view/3958
id_number: oai:ojs.pkp.sfu.ca:article/3958
full_text_status: none
publication: Multidisciplinary Journal of Science and Technology
citation:   Kurbanova, Z.Ch., Z.A, Sayfuddinova, Begmatova3, .A.  (2025) CLINICAL DYNAMICS OF HEMOSTATIC SYSTEM PARAMETERS AND THE ROLE OF BIOMARKERS IN PATIENTS WITH IMMUNE MICROTHROMBOVASCULITIS UNDER ANTICOAGULANT THERAPY.  Multidisciplinary Journal of Science and Technology.